• Genoa in the News

Chain Drug Review features Genoa Healthcare’s integrated pharmacy model and the positive impact of community pharmacies on opioid use disorder

May 12th, 2023

Millions of Americans are living with mental illness, substance use disorder, and other complex, chronic health conditions. Recently, Chain Drug Review featured Genoa, which provides personalized, compassionate care using its integrated, on-site model to meet the needs of these often-medically underserved communities and provide accessible care.

“With every pharmacy we open and every medication we fill, we’re committed to serving our communities with the best-quality pharmacy care possible,” said Todd Gustin, CEO of Genoa, in the article. “We’re making a difference in the lives of people experiencing very tough circumstances.”

The article also shared results of a first-of-its-kind study from researchers at Brown University, Rhode Island Hospital and the University of Rhode Island that Genoa participated in which found that pharmacists — not just physicians at clinics and doctor’s offices — can safely and effectively start patients with opioid use disorder on the lifesaving medication buprenorphine.

The study documents the experiences of 100 patients who started taking buprenorphine after visiting a specially trained pharmacist for their care. Once stabilized on the medication, 58 patients were randomly assigned to receive either continued care in the pharmacy or usual care in a clinic or physician’s office.

After one month, the patients in the pharmacy care group showed dramatically higher rates of retention: 25 patients (89%) continued to receive treatment in the pharmacy compared to five (17%) in the usual care group.

“The study results are encouraging, and they highlight the role pharmacists can play in achieving positive health outcomes,” Tasha Hennessy, COO of Genoa, was quoted in the article. “The patients in this population just want to get healthy, but unfortunately they often experience barriers to care that make it hard for them to do so.”

Read the full article in Chain Drug Review’s recent issue.

Recent Posts


  • Blog Post
Commitment to community wellness: immunization clinics and health advocacy

In Jackson Miss., a dedicated Genoa pharmacy team led by site manager Stephanie Lidell, Pharm D, along with Stephanie Tucker and Justin Barnes, Business Development Representatives at Genoa Healthcare, organized...

  • Clinical Insights
Brixadi®: 3 things to know about the buprenorphine treatment option

Staying on top of new medication therapy options for your consumers living with opioid use disorder (OUD) can be difficult. Learn how the new FDA-approved medication, Brixadi®, can help support...

  • Pharmacy Openings
Announcing three new pharmacy openings!

We’re excited to announce the opening of three pharmacies last month. We welcome all new pharmacy staff to the team and are excited to partner with these organizations to serve...

  • Blog Post
Mental health organizations to donate to this Giving Tuesday

Looking to make a difference this Giving Tuesday? Please consider donating to one of these mental health organizations. American Foundation for Suicide Prevention (AFSP): AFSP is a national charity that supports...